1 Product identity
Ingredient risk
1 ingredient to use with caution

Hyaluronic Acid

BrandGlucoflex→Non-Nutrient/Non-Botanical Tablet or Pill 9 ingredients 1 caution DSLD #7069
Net contents: 30 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2012-03-23
2 Ingredients (9)
IngredientGroupSafety
Glucosamine HClGlucosamine Hydrochloride—
Hyaluronic Acid Sodium SaltHyaluronic acidGenerally Safe
Dicalcium PhosphateCalciumConditionally Safe
Microcrystalline CelluloseCellulose—
Croscarmellose SodiumCroscarmellose Sodium—
Stearic AcidStearic Acid—
Magnesium StearateMagnesiumUse with Caution
SilicaSiliconGenerally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Glucosamine — Limited Evidence
⚠ Shellfish allergy
⚠ May affect glucose
Hyaluronic acid — Generally Safe
⚠ Hypertension
⚠ Fluid retention
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
GLA — Limited Evidence
⚠ May lower seizure threshold
⚠ Borage oil: hepatotoxic unless PA-free
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID7069
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-03-23
6 More from Glucoflex
View Glucoflex Safety Scorecard → 3 products
Glucosamine & Chondroitin SulfateGlucosamine & Chondroitin Sulfate
7 Cite this page
Vancouver
Pkhakadze G. Hyaluronic Acid — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 17]. Available from: https://supplement.ge/products/hyaluronic-acid-7069/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network